{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:02:56Z","timestamp":1786579376089,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11596-024-2898-7","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T01:01:24Z","timestamp":1721696484000},"page":"841-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Traditional Chinese Medicine Erhuang Suppository for Treatment of Persistent High-risk Human Papillomavirus Infection and Its Impact on Transcriptome of Uterine Cervix"],"prefix":"10.1007","volume":"44","author":[{"given":"Zi-zhuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"issue":"10167","key":"2898_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet, 2019,393(10167):169\u2013182","journal-title":"Lancet"},{"key":"2898_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2020.10.034","volume":"497","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Cai X, Shen F, et al. HPV postinfection microenvironment and cervical cancer. Cancer Lett, 2021,497:243\u2013254","journal-title":"Cancer Lett"},{"issue":"1","key":"2898_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.30623","volume":"141","author":"SR Hoffman","year":"2017","unstructured":"Hoffman SR, Le T, Lockhart A, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review. Int J Cancer, 2017,141(1):8\u201323","journal-title":"Int J Cancer"},{"key":"2898_CR4","doi-asserted-by":"publisher","first-page":"1112513","DOI":"10.3389\/fimmu.2023.1112513","volume":"14","author":"RV Hewavisenti","year":"2023","unstructured":"Hewavisenti RV, Arena J, Ahlenstiel CL, et al. Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk. Front Immunol, 2023,14:1112513","journal-title":"Front Immunol"},{"key":"2898_CR5","doi-asserted-by":"publisher","first-page":"929666","DOI":"10.3389\/fcimb.2022.929666","volume":"12","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Li X, Jiao Y, et al. High-Risk Human Papillomavirus Oncogenic E6\/E7 mRNAs Splicing Regulation. Front Cell Infect Microbiol, 2022,12:929666","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"2898_CR6","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1002\/cam4.1501","volume":"7","author":"Z Hu","year":"2018","unstructured":"Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med, 2018,7(10):5217\u20135236","journal-title":"Cancer Med"},{"issue":"9895","key":"2898_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, et al. Human papillomavirus and cervical cancer. Lancet, 2013,382(9895):889\u2013899","journal-title":"Lancet"},{"issue":"1","key":"2898_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.sxmr.2019.09.005","volume":"8","author":"SL Bedell","year":"2020","unstructured":"Bedell SL, Goldstein LS, Goldstein AR, et al. Cervical Cancer Screening: Past, Present, and Future. Sex Med Rev, 2020,8(1):28\u201337","journal-title":"Sex Med Rev"},{"issue":"Suppl 8","key":"2898_CR9","doi-asserted-by":"publisher","first-page":"S849","DOI":"10.1093\/cid\/civ813","volume":"61","author":"IU Park","year":"2015","unstructured":"Park IU, Introcaso C, Dunne EF. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis, 2015,61(Suppl8):S849\u2013855","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2898_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00262-004-0501-4","volume":"53","author":"S Hallez","year":"2004","unstructured":"Hallez S, Simon P, Maudoux F, et al. Phase I\/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia. Cancer Immunol Immunother, 2004,53(7):642\u2013650","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"2898_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ygyno.2020.08.025","volume":"159","author":"G Bogani","year":"2020","unstructured":"Bogani G, V DID, Sopracordevole F, et al. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study. Gynecol Oncol, 2020,159(3):636\u2013641","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2898_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/vaccines11030698","volume":"11","author":"A Giannini","year":"2023","unstructured":"Giannini A, Di Donato V, Sopracordevole F, et al. Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization. Vaccines, 2023,11(3):698","journal-title":"Vaccines"},{"key":"2898_CR13","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.pharmthera.2021.107843","volume":"225","author":"K Huang","year":"2021","unstructured":"Huang K, Zhang P, Zhang Z, et al. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms. Pharmacol Ther, 2021,225:107843","journal-title":"Pharmacol Ther"},{"issue":"12","key":"2898_CR14","first-page":"881","volume":"18","author":"YJ Dai","year":"2020","unstructured":"Dai YJ, Wan SY, Gong SS, et al. Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19. Chin J Nat Med, 2020,18(12):881\u2013889","journal-title":"Chin J Nat Med"},{"key":"2898_CR15","doi-asserted-by":"publisher","first-page":"101139","DOI":"10.1016\/j.eujim.2020.101139","volume":"37","author":"Z Zhuang","year":"2020","unstructured":"Zhuang Z, Wen J, Zhang L, et al. Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection? Eur J Integr Med, 2020,37:101139","journal-title":"Eur J Integr Med"},{"issue":"10","key":"2898_CR16","doi-asserted-by":"publisher","first-page":"e12894","DOI":"10.1111\/cpr.12894","volume":"53","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang S, Wang K, et al. Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products. Cell Prolif, 2020,53(10):e12894","journal-title":"Cell Prolif"},{"issue":"24","key":"2898_CR17","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1097\/CM9.0000000000001141","volume":"133","author":"XL Su","year":"2020","unstructured":"Su XL, Wang JW, Che H, et al. Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer. Chin Med J (Engl), 2020,133(24):2987\u20132997","journal-title":"Chin Med J (Engl)"},{"key":"2898_CR18","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.phrs.2021.105728","volume":"170","author":"S Wang","year":"2021","unstructured":"Wang S, Fu JL, Hao HF, et al. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res, 2021,170:105728","journal-title":"Pharmacol Res"},{"issue":"19","key":"2898_CR19","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.3390\/nu14193958","volume":"14","author":"C Feng","year":"2022","unstructured":"Feng C, Li A, Yin C, et al. RealgarAlleviated Neuroinflammation Induced by High Protein and High Calorie Diet in Rats via the Microbiota-Gut-Brain Axis. Nutrients, 2022,14(19):3958","journal-title":"Nutrients"},{"key":"2898_CR20","doi-asserted-by":"publisher","first-page":"102229","DOI":"10.1016\/j.cbpa.2022.102229","volume":"72","author":"SE Hollow","year":"2023","unstructured":"Hollow SE, Johnstone TC. Realgar and arsenene nanomaterials as arsenic-based anticancer agents. Curr Opin Chem Biol, 2023,72:102229","journal-title":"Curr Opin Chem Biol"},{"key":"2898_CR21","doi-asserted-by":"publisher","first-page":"1143173","DOI":"10.3389\/fmicb.2023.1143173","volume":"14","author":"L Luo","year":"2023","unstructured":"Luo L, Li C, Huang N, et al. Traditional mineral medicine realgar and Realgar-Indigo naturalis formula potentially exerted therapeutic effects by altering the gut microbiota. Front Microbiol, 2023,14:1143173","journal-title":"Front Microbiol"},{"key":"2898_CR22","doi-asserted-by":"publisher","first-page":"775084","DOI":"10.3389\/fphar.2021.775084","volume":"12","author":"L He","year":"2021","unstructured":"He L, Zhong Z, Chen M, et al. Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers. Front Pharmacol, 2021,12:775084","journal-title":"Front Pharmacol"},{"issue":"1","key":"2898_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1142\/S0192415X20500093","volume":"48","author":"J Huang","year":"2020","unstructured":"Huang J, Guo W, Cheung F, et al. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma. Am J Chin Med, 2020,48(1):161\u2013182","journal-title":"Am J Chin Med"},{"issue":"2","key":"2898_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrg1272","volume":"5","author":"AL Barab\u00e1si","year":"2004","unstructured":"Barab\u00e1si AL, Oltvai ZN. Network biology: understanding the cell\u2019s functional organization. Nat Rev Genet, 2004,5(2):101\u2013113","journal-title":"Nat Rev Genet"},{"issue":"13","key":"2898_CR25","doi-asserted-by":"publisher","first-page":"111890","DOI":"10.1016\/j.celrep.2022.111890","volume":"41","author":"Z Wang","year":"2022","unstructured":"Wang Z, Qin X, Hu D, et al. Akkermansia supplementation reverses the tumor-promoting effect of the fecal microbiota transplantation in ovarian cancer. Cell Rep, 2022,41(13):111890","journal-title":"Cell Rep"},{"key":"2898_CR26","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.biopha.2018.06.149","volume":"106","author":"RP Araldi","year":"2016","unstructured":"Araldi RP, Sant\u2019Ana TA, M\u00f6dolo DG, et al. The human papillomavirus (HPV)-related cancer biology: An overview. Biomed Pharmacother, 2016,106:1537\u20131556","journal-title":"Biomed Pharmacother"},{"key":"2898_CR27","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","volume":"156","author":"R Li","year":"2020","unstructured":"Li R, Hou Y, Huang J, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res, 2020,156:104761","journal-title":"Pharmacol Res"},{"key":"2898_CR28","doi-asserted-by":"publisher","first-page":"111044","DOI":"10.1016\/j.biopha.2020.111044","volume":"133","author":"K Wang","year":"2021","unstructured":"Wang K, Chen Q, Shao Y, et al. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother, 2021,133:111044","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"2898_CR29","first-page":"1068","volume":"40","author":"L Li","year":"2021","unstructured":"Li L, Wang L, Xiao S, et al. Effect of nanorealgar on proliferation and apoptosis of human cervical carcinoma cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban (Chinese), 2021,40(10):1068\u20131075","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban (Chinese)"},{"issue":"2","key":"2898_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7150\/ijbs.67770","volume":"18","author":"C Hu","year":"2022","unstructured":"Hu C, Liu T, Han C, et al. HPV E6\/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m(6)A-MYC expression. Int J Biol Sci, 2022,18(2):507\u2013521","journal-title":"Int J Biol Sci"},{"issue":"15","key":"2898_CR31","doi-asserted-by":"publisher","first-page":"8075","DOI":"10.3390\/ijms22158075","volume":"22","author":"OJ Kwon","year":"2021","unstructured":"Kwon OJ, Noh JW, Lee BC. Mechanisms and Effect of Coptidis Rhizoma on Obesity-Induced Inflammation: In Silico and In Vivo Approaches. Int J Mol Sci, 2021,22(15):8075","journal-title":"Int J Mol Sci"},{"key":"2898_CR32","doi-asserted-by":"publisher","first-page":"1037856","DOI":"10.3389\/fphar.2022.1037856","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Hua Y, Chen W, et al. Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis. Front Pharmacol, 2022,13:1037856","journal-title":"Front Pharmacol"},{"issue":"9","key":"2898_CR33","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.3390\/ijms22094797","volume":"22","author":"SY Kim","year":"2021","unstructured":"Kim SY, Park C, Kim MY, et al. ROS-Mediated Anti-Tumor Effect of Coptidis Rhizoma against Human Hepatocellular Carcinoma Hep3B Cells and Xenografts. Int J Mol Sci, 2021,22(9):4797","journal-title":"Int J Mol Sci"},{"key":"2898_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jep.2015.10.028","volume":"176","author":"N Wang","year":"2015","unstructured":"Wang N, Tan HY, Li L, et al. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives. J Ethnopharmacol, 2015,176:35\u201348","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"2898_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11655-016-2584-0","volume":"24","author":"LN Liang","year":"2018","unstructured":"Liang LN, Bai YY, Tang YZ, et al. Contribution of Borneolum syntheticum to the Intervention Effect of Liuwei Dihuang Pill on Experimental Retinal Degeneration. Chin J Integr Med, 2018,24(6):442\u2013447","journal-title":"Chin J Integr Med"},{"issue":"3","key":"2898_CR36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.etap.2015.09.016","volume":"40","author":"KS Abdul","year":"2015","unstructured":"Abdul KS, Jayasinghe SS, Chandana EP, et al. Arsenic and human health effects: A review. Environ Toxicol Pharmacol, 2015,40(3):828\u2013846","journal-title":"Environ Toxicol Pharmacol"},{"issue":"2","key":"2898_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41556-020-00619-0","volume":"23","author":"C Chumduri","year":"2021","unstructured":"Chumduri C, Gurumurthy RK, Berger H, et al. Opposing Wnt signals regulate cervical squamocolumnar homeostasis and emergence of metaplasia. Nat Cell Biol, 2021,23(2):184\u2013197","journal-title":"Nat Cell Biol"},{"issue":"6","key":"2898_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3892\/ol.2023.13832","volume":"25","author":"B Deng","year":"2023","unstructured":"Deng B, Li A, Zhu Y, et al. SHCBP1 contributes to the proliferation and self-renewal of cervical cancer cells and activation of the NF-\u03baB signaling pathway through EIF5A. Oncol Lett, 2023,25(6):246","journal-title":"Oncol Lett"},{"issue":"4","key":"2898_CR39","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1002\/jcp.30134","volume":"236","author":"H Ma","year":"2021","unstructured":"Ma H, Han F, Yan X, et al. PBK promotes aggressive phenotypes of cervical cancer through ERK\/c-Myc signaling pathway. J Cell Physiol, 2021,236(4):2767\u20132781","journal-title":"J Cell Physiol"},{"issue":"16","key":"2898_CR40","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.3390\/ijms21165612","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Park S, Chang Y, et al. Synergetic Effects of Intronic Mature miR-944 and ANp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line. Int J Mol Sci, 2020,21(16):5612","journal-title":"Int J Mol Sci"},{"key":"2898_CR41","doi-asserted-by":"publisher","first-page":"113729","DOI":"10.1016\/j.bcp.2019.113729","volume":"172","author":"FE Marquard","year":"2020","unstructured":"Marquard FE, J\u00fccker M. PI3K\/AKT\/mTOR signaling as a molecular target in head and neck cancer. Biochem Pharmacol, 2020,172:113729","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2898_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s10020-021-00384-2","volume":"27","author":"J Zeng","year":"2021","unstructured":"Zeng J, He SL, Li LJ, et al. Hsp90 upregulates PD-L1 to promote HPV-positive cervical cancer via HER2\/PI3K\/AKT pathway. Mol Med, 2021,27(1):130","journal-title":"Mol Med"},{"key":"2898_CR43","doi-asserted-by":"publisher","first-page":"103675","DOI":"10.1016\/j.critrevonc.2022.103675","volume":"174","author":"R Bhattacharjee","year":"2022","unstructured":"Bhattacharjee R, Das SS, Biswal SS, et al. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Crit Rev Oncol Hematol, 2022,174:103675","journal-title":"Crit Rev Oncol Hematol"},{"key":"2898_CR44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fonc.2019.00173","volume":"9","author":"JA Smith","year":"2019","unstructured":"Smith JA, Mathew L, Gaikwad A, et al. From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections. Front Oncol, 2019,9:173","journal-title":"Front Oncol"},{"issue":"8","key":"2898_CR45","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/diagnostics12081906","volume":"12","author":"K Chaberek","year":"2022","unstructured":"Chaberek K, Mrowiec M, Kaczmarek M, et al. The Creation of the Suppressive Cancer Microenvironment in Patients with HPV-Positive Cervical Cancer. Diagnostics (Basel), 2022,12(8):1906","journal-title":"Diagnostics (Basel)"},{"issue":"18","key":"2898_CR46","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1158\/1078-0432.CCR-20-2833","volume":"27","author":"L Ferrall","year":"2021","unstructured":"Ferrall L, Lin KY, Roden RBS, et al. Cervical Cancer Immunotherapy: Facts and Hopes. Clin Cancer Res, 2021,27(18):4953\u20134973","journal-title":"Clin Cancer Res"},{"issue":"13","key":"2898_CR47","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.molimm.2010.05.008","volume":"47","author":"JR Dunkelberger","year":"2010","unstructured":"Dunkelberger JR, Song WC. Role and mechanism of action of complement in regulating T-cell immunity. Mol Immunol, 2010,47(13):2176\u20132186","journal-title":"Mol Immunol"},{"key":"2898_CR48","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3389\/fphar.2019.01596","volume":"10","author":"YL Shen","year":"2019","unstructured":"Shen YL, Jiang YP, Li XQ, et al. ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6\/JAK\/STAT3 Signaling Pathway. Front Pharmacol, 2019,10:1596","journal-title":"Front Pharmacol"},{"issue":"1","key":"2898_CR49","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1186\/s12885-022-10179-1","volume":"22","author":"MT Bruno","year":"2022","unstructured":"Bruno MT, Cassaro N, Mazza G, et al. Spontaneous regression of cervical intraepithelial neoplasia 3 in women with a biopsy-cone interval of greater than 11 weeks. BMC Cancer, 2022,22(1):1072","journal-title":"BMC Cancer"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2898-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2898-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2898-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T22:14:01Z","timestamp":1733868841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2898-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2898"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2898-7","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}